Ambev S.A. (ABEV)
| Market Cap | 49.49B +44.7% |
| Revenue (ttm) | 17.04B -3.8% |
| Net Income | 3.14B +10.1% |
| EPS | 0.20 +10.8% |
| Shares Out | 15.45B |
| PE Ratio | 15.78 |
| Forward PE | 14.99 |
| Dividend | $0.12 (3.84%) |
| Ex-Dividend Date | Sep 23, 2026 |
| Volume | 17,949,705 |
| Open | 3.220 |
| Previous Close | 3.190 |
| Day's Range | 3.150 - 3.220 |
| 52-Week Range | 2.100 - 3.450 |
| Beta | 0.25 |
| Analysts | Hold |
| Price Target | 3.35 (+5.02%) |
| Earnings Date | Oct 29, 2026 |
About ABEV
Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, soft drinks, malt and food, and other beverages in Brazil, Central America and Caribbean, Latin America South, and Canada. The company offers beer, ready-to-drink cocktails and spritzers, soft drinks, water, teas, and isotonic drinks under the Brahma, Skol, Antarctica, Original, Quilmes, Andes Origen, Patricia, Paceha, Huari, Pilsen, Presidente, Balboa, Guaraná Antarctica, and Beats brands. It sells its products to distributors, supermar... [Read more]
Financial Performance
In 2025, Ambev's revenue was 88.24 billion, a decrease of -1.35% compared to the previous year's 89.45 billion. Earnings were 15.50 billion, an increase of 7.38%.
Financial numbers in BRL Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for ABEV stock is "Hold." The 12-month stock price target is $3.35, which is an increase of 5.02% from the latest price.
News
Is Ambev (ABEV) a Solid Growth Stock? 3 Reasons to Think "Yes"
Ambev (ABEV) could produce exceptional returns because of its solid growth attributes.
ABEV Downgraded by B of A Securities -- Rating Changed to Underperform
ABEV Downgraded by B of A Securities -- Rating Changed to Underperform
Ambev downgraded to Underperform from Neutral at BofA
BofA downgraded Ambev (ABEV) to Underperform from Neutral with an unchanged price target of $3.30. The stock went up by 3% since the first round of Brazil’s presidential election, reflecting…
Ambev price target lowered to $2.85 from $2.90 at UBS
UBS lowered the firm’s price target on Ambev (ABEV) to $2.85 from $2.90 and keeps a Sell rating on the shares.
Ambev (ABEV) Q2 2026 Earnings Call Transcript
Premium beer surged 20% as World Cup activation drove margin expansion.
Ambev Q2 Earnings Call Highlights
Ambev NYSE: ABEV reported stronger second-quarter operating performance, led by beer-volume growth, revenue management and margin expansion, while continuing to invest in brand activations tied to the...
Ambev Earnings Call Transcript: Q2 2026
Second quarter and first half results showed strong volume, revenue, and EBITDA growth, with margin expansion and robust cash flow. Premiumization, digital ecosystem gains, and disciplined capital allocation supported broad-based performance across markets, despite weather and macro headwinds.
Ambev Earnings release: Q2 2026
Ambev released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Ambev Quarterly report: Q2 2026
Ambev has published its Q2 2026 quarterly earnings report on July 30, 2026.
Ambev Slides: Q2 2026
Ambev has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
ABEV Looks 11.9% Overvalued on GF Value™ as Dividend Sustainability Remains Key
ABEV Looks 11.9% Overvalued on GF Value™ as Dividend Sustainability Remains Key
Scotiabank downgrades Ambev on valuation, tougher compares
Scotiabank downgraded Ambev (ABEV) to Sector Perform from Outperform with an unchanged price target of R$16. The company’s positives are fully priced into the shares and the upside is now…
Ambev downgraded to Sector Perform from Outperform at Scotiabank
Scotiabank downgraded Ambev (ABEV) to Sector Perform from Outperform with a R$16 price target
Ambev upgraded to Buy from Neutral at BTG Pactual
BTG Pactual upgraded Ambev (ABEV) to Buy from Neutral with a R$20 price target
Ambev price target raised to $2.90 from $2.65 at UBS
UBS raised the firm’s price target on Ambev (ABEV) to $2.90 from $2.65 and keeps a Sell rating on the shares.
Stock Market Today, May 8: Ambev Gained 13% This Week on Strong Earnings
Expand NYSE: ABEV Ambev Today's Change (0.30%) $0.01 Current Price $3.29 Key Data Points Market Cap $51B Day's Range $3.26 - $3.35 52wk Range $2.10 - $3.45 Volume 74M Avg Vol 25M Gross Margin 47.97% D...
Ambev price target raised to $3.50 from $3 at Barclays
Barclays raised the firm’s price target on Ambev (ABEV) to $3.50 from $3 and keeps an Equal Weight rating on the shares.
Ambev Earnings Call Transcript: Q1 2026
Solid Q1 performance with 9.6% net revenue growth and 10.1% EBITDA growth, driven by strong premium and digital platform momentum. Cost pressures are expected to ease, and guidance for Brazil beer COGS is maintained at 4.5%-7.5% for 2026.
Ambev Earnings release: Q1 2026
Ambev released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
Ambev Slides: Q1 2026
Ambev has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Ambev Quarterly report: Q1 2026
Ambev has published its Q1 2026 quarterly earnings report on May 5, 2026.
Jet Fuel Prices Are Soaring. Airlines and Travelers Will Feel It.
Jet fuel prices have jumped far more than crude oil since fighting in Iran began, pressuring airlines like Delta Air Lines and forcing capacity cuts.
Ambev S.A. (ABEV) Faces Downgrade from UBS Amid Valuation Concerns
Ambev S.A. (ABEV) Faces Downgrade from UBS Amid Valuation Concerns
ABEV Downgraded by UBS -- Rating Changed to Sell
ABEV Downgraded by UBS -- Rating Changed to Sell